The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.
Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.
Parent entities and officers
Active
3
- 1
Brar, Ricky
Born in March 1972Individual (3 offsprings)Officer
2024-02-07 ~ nowOF - Director → CIF 0 - 2
Brar, Swarandeep Singh
Born in February 1982Individual (4 offsprings)Officer 2019-03-28 ~ nowOF - Director → CIF 0 - 3
610 - 999, Canada Place, Vancouver, Bc, CanadaCorporate (2 offsprings)Person with significant control 2020-04-01 ~ nowPE - Ownership of shares – 75% or more → CIF 0
Ceased
5
- 1
Tiley, John Malcolm
Director Of Production born in April 1957Individual (12 offsprings)Officer 2015-10-14 ~ 2016-08-06OF - Director → CIF 0 - 2
Stephenson, Audrey Lillian
Born in July 1953Individual (3 offsprings)Officer 2014-09-01 ~ 2018-04-17OF - Director → CIF 0Mrs Audrey Lillian Stephenson
Born in July 1953Individual (3 offsprings)Person with significant control 2017-03-28 ~ 2018-04-17PE - Ownership of shares – More than 25% but not more than 50% → CIF 0 - 3
Agramont, Marcos
Ceo Parent Company born in August 1980IndividualOfficer 2018-04-17 ~ 2019-03-28OF - Director → CIF 0Mr Marcos Agramont
Born in August 1980IndividualPerson with significant control 2018-04-17 ~ 2018-04-17PE - Ownership of shares – 75% or more as a member of a firm → CIF 0PE - Has significant influence or control as a member of a firm → CIF 0PE - Ownership of voting rights - 75% or more as a member of a firm → CIF 0PE - Right to appoint or remove directors as a member of a firm → CIF 0 - 4
Stephenson, Michael
President born in June 1953Individual (5 offsprings)Officer 2014-03-13 ~ 2018-05-17OF - Director → CIF 0Mr Michael Stephenson
Born in June 1953Individual (5 offsprings)Person with significant control 2016-07-01 ~ 2018-04-17PE - Ownership of shares – More than 25% but not more than 50% → CIF 0 - 5200, Granville St, Vancouver Bc V6c 1s4, CanadaCorporatePerson with significant control2018-04-17 ~ 2019-03-28PE - Ownership of shares – 75% or more → CIF 0
Company in focus
BSPG LABORATORIES LIMITED
Previous names
BIOSYNTHESIS PHARMA UK LTD. - 2014-06-30
BSPG LABORATORIES LTD - 2023-01-26
BIOSYNTHESIS PHARMA UK LTD - 2018-08-16
BRAINS BIOCEUTICAL LABORATORIES LIMITED - 2023-03-06
BSPG LABORATORIES LTD - 2018-07-25
Standard Industrial Classification
86900 - Other Human Health Activities
Brief company account
Intangible Assets
1,582,400 GBP2024-03-31
1,797,874 GBP2023-03-31
Property, Plant & Equipment
5,348,480 GBP2024-03-31
5,892,552 GBP2023-03-31
Fixed Assets
6,930,880 GBP2024-03-31
7,690,426 GBP2023-03-31
Total Inventories
1,307,914 GBP2024-03-31
1,654,400 GBP2023-03-31
Debtors
4,308,503 GBP2024-03-31
1,124,570 GBP2023-03-31
Cash at bank and in hand
587,038 GBP2024-03-31
103,122 GBP2023-03-31
Current Assets
6,203,455 GBP2024-03-31
2,882,092 GBP2023-03-31
Net Current Assets/Liabilities
-11,151,042 GBP2024-03-31
-10,571,364 GBP2023-03-31
Total Assets Less Current Liabilities
-4,220,162 GBP2024-03-31
-2,880,938 GBP2023-03-31
Creditors
Non-current
-2,123,218 GBP2024-03-31
-2,422,369 GBP2023-03-31
Net Assets/Liabilities
-6,651,807 GBP2024-03-31
-5,303,307 GBP2023-03-31
Equity
Called up share capital
300 GBP2024-03-31
300 GBP2023-03-31
Retained earnings (accumulated losses)
-6,652,107 GBP2024-03-31
-5,303,607 GBP2023-03-31
Average Number of Employees
242023-04-01 ~ 2024-03-31
322022-04-01 ~ 2023-03-31
Intangible Assets - Gross Cost
Other
2,471,389 GBP2024-03-31
2,471,389 GBP2023-03-31
Intangible Assets
Other
1,582,400 GBP2024-03-31
1,797,874 GBP2023-03-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
1,818,853 GBP2024-03-31
1,763,471 GBP2023-03-31
Furniture and fittings
62,101 GBP2024-03-31
62,101 GBP2023-03-31
Computers
86,624 GBP2024-03-31
58,088 GBP2023-03-31
Property, Plant & Equipment - Gross Cost
6,948,395 GBP2024-03-31
6,806,901 GBP2023-03-31
Land and buildings, Under hire purchased contracts or finance leases
4,980,817 GBP2024-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
892,342 GBP2024-03-31
674,344 GBP2023-03-31
Furniture and fittings
29,528 GBP2024-03-31
21,385 GBP2023-03-31
Computers
45,018 GBP2024-03-31
33,222 GBP2023-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
1,599,915 GBP2024-03-31
914,349 GBP2023-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
217,998 GBP2023-04-01 ~ 2024-03-31
Furniture and fittings
8,143 GBP2023-04-01 ~ 2024-03-31
Computers
11,796 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
685,566 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Land and buildings, Under hire purchased contracts or finance leases
633,027 GBP2024-03-31
Property, Plant & Equipment
Land and buildings, Under hire purchased contracts or finance leases
4,347,790 GBP2024-03-31
Plant and equipment
926,511 GBP2024-03-31
1,089,127 GBP2023-03-31
Furniture and fittings
32,573 GBP2024-03-31
40,716 GBP2023-03-31
Computers
41,606 GBP2024-03-31
24,866 GBP2023-03-31
Raw Materials
223,672 GBP2024-03-31
343,014 GBP2023-03-31
Finished Goods
1,026,471 GBP2024-03-31
1,311,585 GBP2023-03-31
Value of work in progress
57,771 GBP2024-03-31
-199 GBP2023-03-31
Trade Debtors/Trade Receivables
Current
3,713,640 GBP2024-03-31
765,078 GBP2023-03-31
Prepayments/Accrued Income
Current
165,761 GBP2024-03-31
204,081 GBP2023-03-31
Other Debtors
Current
187,915 GBP2024-03-31
10,860 GBP2023-03-31
Amount of value-added tax that is recoverable
Current
241,187 GBP2024-03-31
144,551 GBP2023-03-31
Trade Creditors/Trade Payables
Current
1,510,601 GBP2024-03-31
228,066 GBP2023-03-31
Other Taxation & Social Security Payable
Current
16,182 GBP2024-03-31
29,336 GBP2023-03-31
Other Creditors
Current
3,596 GBP2023-03-31
Accrued Liabilities/Deferred Income
Current
549,490 GBP2023-03-31
Other Creditors
Non-current
2,123,218 GBP2024-03-31
2,422,369 GBP2023-03-31
BSPG LABORATORIES LIMITED
InfoBIOSYNTHESIS PHARMA UK LTD. - 2014-06-30BSPG LABORATORIES LTD - 2014-06-30BIOSYNTHESIS PHARMA UK LTD - 2014-06-30BRAINS BIOCEUTICAL LABORATORIES LIMITED - 2014-06-30BSPG LABORATORIES LTD - 2014-06-30Registered number 089387313rd Floor, South Pod, Discovery Park House, Ramsgate Road, Sandwich CT13 9NDPRIVATE LIMITED COMPANY incorporated on 2014-03-13 (11 years 9 months). The company status is Active.The last date of confirmation statement was made at 2025-03-13CIF 0
Offspring entities and appointments
Active
0
- Not found in our database.
The content of this website is protected by AgonGuard.
© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.
Contains public sector information retrieved at 12 November 2025 and
licensed under the Open Government Licence v3.0.